{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:41:12Z","timestamp":1784641272188,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jdcr.2021.12.028","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T14:30:25Z","timestamp":1640701825000},"page":"72-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cutaneous leishmaniasis due to Leishmania aethiopica: A therapeutic challenge"],"prefix":"10.1016","volume":"20","author":[{"given":"Laura","family":"Mengeot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Cyr","family":"Yombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Baeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2021.12.028_bib1","series-title":"Guideline for Diagnosis, Treatment & Prevention of Leishmaniasis in Ethiopia","year":"2013"},{"issue":"5","key":"10.1016\/j.jdcr.2021.12.028_bib2","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jdcr.2021.12.028_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1007-4376(09)60032-0","article-title":"A review of leishmaniasis in Eastern Africa","volume":"23","author":"Ngure","year":"2009","journal-title":"J Nanjing Med Uni"},{"issue":"3","key":"10.1016\/j.jdcr.2021.12.028_bib4","doi-asserted-by":"crossref","first-page":"e0004495","DOI":"10.1371\/journal.pntd.0004495","article-title":"Treatment of cutaneous leishmaniasis caused by Leishmania aethiopica: a systematic review","volume":"10","author":"van Griensven","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.jdcr.2021.12.028_bib5","doi-asserted-by":"crossref","first-page":"e2457","DOI":"10.1093\/cid\/ciaa1238","article-title":"Efficacy and tolerability of miltefosine in the treatment of cutaneous leishmaniasis","volume":"73","author":"Ware","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jdcr.2021.12.028_bib6","doi-asserted-by":"crossref","first-page":"e0009460","DOI":"10.1371\/journal.pntd.0009460","article-title":"Miltefosine for the treatment of cutaneous leishmaniasis\u2014a pilot study from Ethiopia","volume":"15","author":"van Henten","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.jdcr.2021.12.028_bib7","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/jac\/dky229","article-title":"In\u00a0vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis","volume":"73","author":"Teixeira de Macedo Silva","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jdcr.2021.12.028_bib8","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1128\/AAC.01150-15","article-title":"Potent in\u00a0vitro antiproliferative synergism of combinations of ergosterol biosynthesis inhibitors against\u00a0Leishmania amazonensis","volume":"59","author":"de Macedo-Silva","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jdcr.2021.12.028_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1468-3083.2008.02805.x","article-title":"A review of photodynamic therapy in cutaneous leishmaniasis","volume":"22","author":"van der Snoek","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jdcr.2021.12.028_bib10","doi-asserted-by":"crossref","first-page":"e13022","DOI":"10.1111\/dth.13022","article-title":"Effective treatment with photodynamic therapy of cutaneous leishmaniasis: a case report","volume":"32","author":"Johansen","year":"2019","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jdcr.2021.12.028_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1067\/mjd.2003.218","article-title":"Treatment of cutaneous leishmaniasis by photodynamic therapy","volume":"48","author":"Gardlo","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jdcr.2021.12.028_bib12","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/jdv.16333","article-title":"Evidence supporting the enhanced efficacy of pentavalent antimonials with adjuvant therapy for cutaneous leishmaniasis: a systematic review and meta-analysis","volume":"34","author":"Husein-ElAhmed","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621009292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621009292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:23:13Z","timestamp":1762474993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512621009292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":12,"alternative-id":["S2352512621009292"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.12.028","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous leishmaniasis due to Leishmania aethiopica: A therapeutic challenge","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}